Skip to main content
. 2020 Jul 28;6(2):e001227. doi: 10.1136/rmdopen-2020-001227

Figure 2.

Figure 2

An overview of treatments used in the included studies of CAPS, HIDS/MKD and TRAPS.

CAPS, cryopyrin-associated periodic syndromes; HIDS, hyperimmunoglobulin D syndrome; MKD, mevalonate kinase deficiency; NSAIDs, non-steroidal anti-inflammatory drugs; TRAPS, tumour necrosis factor receptor-associated periodic syndrome.